Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico

Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico

Authors

  • Gianluca Falcitelli Consulente statistico, via G. Barzellotti 8, Roma 

  • Giuseppe Armentano Specialista in Diabetologia e Malattie del Ricambio, Direttore centro Diabetologico DEA di Rossano (CS) 

  • Corrado Pugliesi Ambulatorio di Diabetologia, Avola 

  • Patrizio Tatti U.O.C.Aziendale, AUSL Roma H, Roma 

  • Antonio Cimino Dirigente Medico, UO di Diabetologia, Spedali Civili di Brescia



DOI:

https://doi.org/10.7175/fe.v7i2.682

Keywords:

Type 2 diabetes, oral anti-diabetics, Insuline, Epidemiology, HbA1c

Abstract

Type 2 diabetes is an important social and health care system variable due to its large diffusion, frequency of clinical complications and its health care costs. The studied population is relative to 4 italian centers distributed all over the country (Brescia, Roma, Rossano Calabro and Avola). This work has the aim to describe the Italian type 2 population according to treatment choice ruled by diabetes stage, glycemia control and HbA1c concentration. The analysis present a description of the therapeutic changes during the year of observation too, giving a complete picture of patients distribution and their treatment path through diabetes evolution in Italy.

Downloads

Published

2006-09-15

How to Cite

Falcitelli, . G., Armentano, . G., Pugliesi, . C., Tatti, . P., & Cimino, . A. (2006). Resistenza all’uso degli ipoglicemizzanti orali nel trattamento del diabete tipo 2: uno studio multicentrico. Farmeconomia. Health Economics and Therapeutic Pathways, 7(2), 125–134. https://doi.org/10.7175/fe.v7i2.682

Issue

Vol. 7 No. 2 (2006)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)